Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3516)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 25, 2022 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Panayiotakopoulos GD, Papadimitriou DT. Rifampicin for COVID-19. World J Virol 2022; 11(2): 90-97 [PMID: 35433334 DOI: 10.5501/wjv.v11.i2.90] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v11/i2/90.htm |
| Number | Citing Articles |
| 1 |
Marwa El-Azazy, Ahmed S. El-Shafie, Reem Al-Mulla, Siham S. Hassan, Hassan I. Nimir. Enhanced adsorptive removal of rifampicin and tigecycline from single system using nano-ceria decorated biochar of mango seed kernel. Heliyon 2023; 9(5): e15802 doi: 10.1016/j.heliyon.2023.e15802
|
| 2 |
Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun. Possible agent for COVID-19 treatment: Rifampicin. World Journal of Virology 2022; 11(5): 391-393 doi: 10.5501/wjv.v11.i5.391
Abstract(261) |
Core Tip(252) |
Full Article(HTML)(1194)
|
Full Article (PDF)-567K(90)
|
Full Article (Word)-105K(38)
|
Audio-48K(0)
|
Peer-Review Report-227K(37)
|
Answering Reviewers-76K(28)
|
Times Cited (0)
|
Total Visits (3250)
|
Open
|
| 3 |
Bhoomika Patel, Anita Sinha, Mamatarani Verma, Dhwani Patel, Jigar Desai. A Study of COVID-19 Infected Patients with Tuberculosis as Comorbidity and on Antitubercular Drug Therapy. Indian Journal of Respiratory Care 2023; 12(3): 239 doi: 10.5005/jp-journals-11010-1058
|
| 4 |
Jasmine Arya, Sweety Dahiya, Anil Kumar Chhillar. Multidrug-resistant Tuberculosis and its Implication with COVID-19. Coronaviruses 2023; 4(3) doi: 10.2174/2666796704666230822113632
|